Hematopoietic Stem Cell Transplantation
"Hematopoietic Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Descriptor ID |
D018380
|
MeSH Number(s) |
E02.095.147.500.500.500 E04.936.225.687.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hematopoietic Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Hematopoietic Stem Cell Transplantation".
This graph shows the total number of publications written about "Hematopoietic Stem Cell Transplantation" by people in this website by year, and whether "Hematopoietic Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 0 | 3 | 1996 | 2 | 1 | 3 | 1997 | 4 | 3 | 7 | 1998 | 7 | 2 | 9 | 1999 | 3 | 1 | 4 | 2000 | 4 | 0 | 4 | 2001 | 4 | 2 | 6 | 2002 | 5 | 2 | 7 | 2003 | 3 | 0 | 3 | 2004 | 3 | 3 | 6 | 2005 | 9 | 1 | 10 | 2006 | 3 | 2 | 5 | 2007 | 4 | 3 | 7 | 2008 | 6 | 1 | 7 | 2009 | 9 | 4 | 13 | 2010 | 13 | 3 | 16 | 2011 | 11 | 8 | 19 | 2012 | 16 | 1 | 17 | 2013 | 13 | 3 | 16 | 2014 | 10 | 3 | 13 | 2015 | 15 | 6 | 21 | 2016 | 26 | 2 | 28 | 2017 | 19 | 4 | 23 | 2018 | 29 | 6 | 35 | 2019 | 15 | 7 | 22 | 2020 | 26 | 5 | 31 | 2021 | 23 | 4 | 27 | 2022 | 25 | 0 | 25 | 2023 | 22 | 1 | 23 | 2024 | 16 | 8 | 24 | 2025 | 4 | 3 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematopoietic Stem Cell Transplantation" by people in Profiles.
-
McMahon C, Raddi MG, Mohan S, Santini V. New Approvals in Low- and Intermediate-Risk Myelodysplastic Syndromes. Am Soc Clin Oncol Educ Book. 2025 Jun; 45(3):e473654.
-
Feist WN, Luna SE, Ben-Efraim K, Filsinger Interrante MV, Amorin A, Johnston NM, Bruun TUJ, Utz A, Ghanim HY, Lesch BJ, McLaughlin TM, Dudek AM, Porteus MH. Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies. Nat Commun. 2025 Apr 01; 16(1):3103.
-
Foeldvari I, Torok KS, Silva J, Denton CP, Henes J, Horvei P, Rosser F, Orteu CH, Li SC, Pain CE, Constantin T, Costa-Reis P, Curran ML, Cutolo M, Hinrichs B, Fligelstone K, Maillard S, Moinzadeh P, Pilkington C, Schraven L, Smith V. Guidance for stem cell therapy for juvenile systemic sclerosis patients. Expert Rev Clin Immunol. 2025 Apr; 21(4):435-450.
-
Walters MC, Eapen M, Liu Y, El Rassi F, Waller EK, Levine JE, Strouse JJ, Antin JH, Parikh SH, Bakshi N, Dampier C, Jaroscak JJ, Bergmann S, Wong T, Kota V, Pace B, Lekakis LJ, Lulla P, Nickel RS, Kasow KA, Popat U, Smith W, Yu L, DiFronzo N, Geller N, Kamani N, Klings ES, Hassell K, Mendizabal A, Sullivan K, Neuberg D, Krishnamurti L. Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Blood Adv. 2025 Mar 11; 9(5):955-965.
-
Khandelwal P, Fish JD, Gorfinkel L, Guilcher GMT, Howell J, Nishitani M, Nuechterlein B, Obeng E, Shah AJ, Cuvelier GDE, Rotz S, Williams KM, Duncan CN. Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation. Transplant Cell Ther. 2025 May; 31(5):297.e1-297.e15.
-
Moreno DF, Oriol A, de la Rubia J, Hern?ndez MT, I?igo MB, Palomera L, de Arriba F, Gonz?lez Y, Teruel AI, Pardo JL, L?pez de la Gu?a A, Sampol A, R?os-Tamayo R, Sureda A, Guti?rrez NC, Calasanz MJ, Ramos MLM, Mateos MV, San Miguel J, Lahuerta JJ, Blad? J, Rosi?ol L. Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials. Clin Lymphoma Myeloma Leuk. 2025 Jul; 25(7):494-504.
-
Georges GE, Khanna D, Wener MH, Mei MG, Mayes MD, Simms RW, Sanchorawala V, Hosing C, Kafaja S, Pawarode A, Holmberg LA, Kolfenbach J, Furst DE, Sullivan KM, Huang S, Gooley T, Nash RA. Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long-Term Outcomes in a Prospective, Single-Arm Trial. Arthritis Rheumatol. 2025 May; 77(5):571-581.
-
Akyol S, Yilmaz E, Tokg?z H, Karaman K, Pekpak E, ?zcan A, Si Msek A, Arslan B, ?ren AC, G?k?eli HS, Acipayam C, G?zel T, Tuncel DA, G?k V, Arslan K, Eken A, Canatan H, Akbayram S, Karak?kc? M, Aycan N, ?aliskan ?, Patiroglu T, ?zdemi R MA, Chiang SCC, Bryceson YT, ?nal E. Clinical spectrum of primary hemophagocytic lymphohistiocytosis: experience of reference centers in Central and Southeast Anatolia. Ann Hematol. 2025 Jan; 104(1):123-130.
-
Sch?fer A, Calderin Sollet Z, Herv? MP, Buhler S, Ferrari-Lacraz S, Norman PJ, Kichula KM, Farias TDJ, Masouridi-Levrat S, Mamez AC, Pradier A, Simonetta F, Chalandon Y, Villard J. NK- and T-cell repertoire is established early after allogeneic HSCT and is imprinted by CMV reactivation. Blood Adv. 2024 11 12; 8(21):5612-5624.
-
Eissa H, Cowan MJ, Heimall J. Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options. Expert Rev Clin Immunol. 2025 Jan; 21(1):73-82.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|